Galapagos CEO Paul Stoffels to step down, former Neumora chief to lead spinout
Paul Stoffels joined Galapagos to turn it around three years ago. But after a series of unsuccessful studies, pipeline changes and a bumpy quest into cell therapy, the Belgian biotech's turnaround never materialized. Galapagos said ...
